SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Angiology
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
0003319708314250v1
0003319708314250v2
60/1/42    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Koshikawa, M.
Right arrow Articles by Ikeda, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koshikawa, M.
Right arrow Articles by Ikeda, U.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Medline Plus Health Information
*Peripheral Arterial Disease
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Elevated Osteopontin Levels in Patients With Peripheral Arterial Disease

Megumi Koshikawa, MD, PhD

Department of Cardiovascular Medicine, Shinshu University Graduate School of Medicine and Shinshu University Hospital, Nagano, Japan

Kazunori Aizawa, MD, PhD

Department of Cardiovascular Medicine, Shinshu University Graduate School of Medicine and Shinshu University Hospital, Nagano, Japan

Hiroki Kasai, MD, PhD

Department of Cardiovascular Medicine, Shinshu University Graduate School of Medicine and Shinshu University Hospital, Nagano, Japan

Atsushi Izawa, MD, PhD

Department of Cardiovascular Medicine, Shinshu University Graduate School of Medicine and Shinshu University Hospital, Nagano, Japan

Takeshi Tomita, MD, PhD

Department of Cardiovascular Medicine, Shinshu University Graduate School of Medicine and Shinshu University Hospital, Nagano, Japan

Setsuo Kumazaki, MD

Department of Cardiovascular Medicine, Shinshu University Graduate School of Medicine and Shinshu University Hospital, Nagano, Japan

Hiroshi Tsutsui, MD, PhD

Department of Cardiovascular Medicine, Shinshu University Graduate School of Medicine and Shinshu University Hospital, Nagano, Japan

Jun Koyama, MD, PhD

Department of Cardiovascular Medicine, Shinshu University Graduate School of Medicine and Shinshu University Hospital, Nagano, Japan

Shigetaka Shimodaira, MD, PhD

Division of Blood Transfusion, Shinshu University Graduate School of Medicine and Shinshu University Hospital, Nagano, Japan

Masafumi Takahashi, MD, PhD

Division of Blood Transfusion, Shinshu University Graduate School of Medicine and Shinshu University Hospital, Nagano, Japan

Uichi Ikeda, MD, PhD

Department of Cardiovascular Medicine, Shinshu University Graduate School of Medicine and Shinshu University Hospital, Nagano, Japan, uikeda{at}hsp.md.shinshu-u.ac.jp

This study was carried out to compare concentrations of osteopontin (OPN) and osteoprotegerin (OPG) in peripheral arterial disease (PAD). The study population consisted of 200 consecutive subjects in whom both OPN/OPG and ankle—brachial index were measured. It was found that OPN levels, but not OPG levels, were significantly more increased in patients with PAD than those without PAD. Serum OPN levels were significantly lower in subjects with angiotensin converting enzyme inhibitors or angiotensin II receptor blockers than those without these agents. In this study, it has been demonstrated for the first time that serum OPN levels are related to PAD. Inhibition of renin— angiotensin system could decrease OPN levels and prevent the progression of PAD.

Key Words: cytokine • peripheral arterial disease • osteopontin

This version was published on February 1, 2009

Angiology, Vol. 60, No. 1, 42-45 (2009)
DOI: 10.1177/0003319708314250


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement